Skip to main content
    D

    Dermata Therapeutics Inc (DRMA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.60
    -0.02 (-3.65%)

    Market Cap: $3.06M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    Dermata Therapeutics Inc (DRMA) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Dermata Therapeutics (DRMA) is expected to report earnings on Mar 24, 2027. In the quarter ended Sep 30, 2026, Dermata Therapeutics reported EPS of -$0.55. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    71%(15/21)
    Avg Surprise
    -5.35%

    Upcoming Estimates

    Reports Mar 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.47
    RangeN/A
    3 analysts
    Revenue Consensus
    $76.50K
    Range$73.50K - $78.75K
    3 analysts
    Reports May 11, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.42
    Range-$0.42 - -$0.42
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current-$0.42
    Revenue Consensus
    $100.00K
    Range$100.00K - $100.00K
    1 analysts

    Next Report

    DRMA has an expected report date of Mar 24, 2027.

    Earnings History

    Of the 21 quarters below that had an estimate, DRMA beat 15 and missed 6. The widest gap in the table came in the quarter ended Sep 30, 2021, when EPS landed 244.00% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.55-$0.55-$0.55 - -$0.55N/AN/AN/A11 up, 0 downNov 10, 2026
    Jun 30, 2026-$0.74-$0.55-$0.55 - -$0.55-34.55%MissN/A10 up, 1 downAug 11, 2026
    Mar 31, 2026-$0.48-$0.53-$0.53 - -$0.53+9.43%BeatN/A11 up, 0 downMay 13, 2026
    Dec 31, 2025-$1.52-$1.54-$1.54 - -$1.54+1.30%BeatN/A10 up, 1 downMar 26, 2026
    Sep 30, 2025-$1.65-$1.59-$1.59 - -$1.59-3.77%MissN/A11 up, 0 downNov 14, 2025
    Jun 30, 2025-$1.66-$2.90N/A+42.76%BeatN/AN/A0 up, 0 downAug 13, 2025
    Mar 31, 2025-$1.25-$0.45N/A-178.11%MissN/AN/A0 up, 0 downMay 14, 2025
    Dec 31, 2024-$13.40-$15.00N/A+10.67%BeatN/AN/A0 up, 0 downMar 17, 2025
    Sep 30, 2024-$20.40-$26.40-$26.40 - -$26.40+22.73%BeatN/A10 up, 0 downNov 13, 2024
    Jun 30, 2024-$41.80-$37.90-$37.90 - -$37.90-10.29%MissN/A10 up, 0 downAug 7, 2024
    Mar 31, 2024-$4.70-$3.60N/A-30.49%MissN/A10 up, 0 downMay 15, 2024
    Dec 31, 2023-$0.21-$0.78N/A+73.08%BeatN/AN/A0 up, 0 downMar 21, 2024
    Sep 30, 2023-$81.00-$94.50N/A+14.29%BeatN/A10 up, 0 downNov 9, 2023
    Jun 30, 2023-$94.50-$138.00N/A+31.52%BeatN/A10 up, 0 downAug 10, 2023
    Mar 31, 2023-$340.50-$397.50N/A+14.34%BeatN/A10 up, 0 downMay 11, 2023
    Dec 31, 2022-$288.00-$480.00N/A+40.00%BeatN/A10 up, 0 downFeb 21, 2023
    Sep 30, 2022-$480.00-$528.00N/A+9.09%BeatN/A10 up, 0 downNov 10, 2022
    Jun 30, 2022-$576.00-$768.00N/A+25.00%BeatN/A10 up, 0 downAug 15, 2022
    Mar 31, 2022-$792.00-$960.00N/A+17.50%BeatN/A10 up, 0 downMay 16, 2022
    Dec 31, 2021-$4.16-$5.68-$6.72 - -$4.64+26.76%BeatN/A20 up, 0 downMar 28, 2022
    Sep 30, 2021-$2,064.00-$600.00-$1,655.17 - -$551.72-244.00%MissN/A2N/ANov 15, 2021
    Jun 30, 2021-$11.20-$22.56N/A+50.35%BeatN/AN/AN/AAug 16, 2021
    Dec 31, 2020-$1.21N/AN/AN/AN/AN/AN/AN/AMar 31, 2021
    Dec 31, 2019-$0.74N/AN/AN/AN/AN/AN/AN/AMar 30, 2020
    Last 24 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$6.08, after -$80.30 the year before. It was -$0.74 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$6.08N/A
    Dec 31, 2024-$80.30N/A
    Dec 31, 2023-$516.21N/A
    Dec 31, 2022-$2,136.00N/A
    Dec 31, 2021-$2,079.36N/A
    Dec 31, 2020-$1.21N/A
    Dec 31, 2019-$0.74N/A

    Frequently Asked Questions About DRMA

    When is Dermata Therapeutics's next earnings date?

    Dermata Therapeutics's next earnings report is expected for Mar 24, 2027.

    What EPS do analysts expect from DRMA next quarter?

    The consensus EPS estimate for Dermata Therapeutics for the quarter ending Dec 31, 2026 is -$0.47 from 3 analysts.

    How often does DRMA beat earnings estimates?

    Dermata Therapeutics beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of -16.19%.